Vilin Bio Med Limited (NSE:VILINBIO)

Vilin Bio Med Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	14.7	0.56	60.49	0.35	0.39
Cash & Short-Term Investments	14.7	0.56	60.49	0.35	0.39
Cash Growth	2520.14%	-99.07%	17434.49%	-11.54%	-16.13%
Accounts Receivable	159.56	63.06	56.84	56.01	77.87
Other Receivables	-	-	-	-	9.19
Receivables	163.89	69.46	67.97	62.56	92.72
Inventory	72.15	44.12	44.68	8.79	22.84
Other Current Assets	23.09	11.47	13.02	8.85	3.14
Total Current Assets	273.83	125.61	186.16	80.54	119.09
Property, Plant & Equipment	28.65	28.53	13.83	15.12	16.5
Long-Term Accounts Receivable	46.94	72.56	77.45	71.61	-
Other Long-Term Assets	-	-	-	-	-0
Total Assets	349.42	277.28	324.04	176.76	135.58

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	33.55	13.89	19.53	11.89	6.41
Accrued Expenses	-	-	-	2.76	1.38
Current Portion of Long-Term Debt	2.06	25.73	66.21	45	45.66
Current Income Taxes Payable	-	5.69	5.69	5.28	0.25
Other Current Liabilities	28.81	0.39	1.3	0.03	-
Total Current Liabilities	64.42	45.7	92.74	64.97	53.7
Long-Term Debt	-	-	2.09	4.31	7.34
Long-Term Deferred Tax Liabilities	-	0.94	0.82	0.7	0.58
Other Long-Term Liabilities	1.28	-	-0	-0	-
Total Liabilities	65.7	46.64	95.64	69.98	61.62

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	152.5	139.5	139.5	99.5	33
Additional Paid-In Capital	-	80	80	-	-
Retained Earnings	-	8.88	6.64	5.02	38.71
Comprehensive Income & Other	131.22	2.26	2.26	2.26	2.26
Shareholders' Equity	283.72	230.64	228.4	106.78	73.96
Total Liabilities & Equity	349.42	277.28	324.04	176.76	135.58

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2.06	25.73	68.3	49.31	53
Net Cash (Debt)	12.64	-25.17	-7.81	-48.97	-52.61
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.90	-1.80	-0.56	-4.92	-6.38
Filing Date Shares Outstanding	14.37	13.95	13.95	9.95	8.25
Total Common Shares Outstanding	14.37	13.95	13.95	9.95	8.25
Working Capital	209.41	79.91	93.42	15.58	65.39
Book Value Per Share	19.75	16.53	16.37	10.73	8.96
Tangible Book Value	283.72	230.64	228.4	106.78	73.96
Tangible Book Value Per Share	19.75	16.53	16.37	10.73	8.96
Land	-	2.12	2.12	2.12	2.12
Buildings	-	34.9	34.9	34.9	34.9
Machinery	-	56.91	56.85	56.84	56.54
Construction In Progress	-	15.68	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error